Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Chief Clinical Officer | August 15, 2023 | August 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date August 15, 2023 · Filed August 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,533,399 |
Reported balance
Holding disclosure · report date 2023-08-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,533,399 F1: Represents (i) 1,513,024 shares of common stock of Alignment Healthcare, Inc. (the "Company") and (ii) 20,375 shares of restricted stock which become vested on 8/1/24, subject to Dr. Furman's continued service to the Company on the vesting date. |
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-03-25 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-08-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: Options are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) 1,513,024 shares of common stock of Alignment Healthcare, Inc. (the "Company") and (ii) 20,375 shares of restricted stock which become vested on 8/1/24, subject to Dr. Furman's continued service to the Company on the vesting date.
F2: Options are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2022 Filed Apr 1, 2022 18:47 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 3,006 | $11.18 | $33,593.85 |
DisclosureSEC source: 0001209191-22-022068 · doc4.xml · nonDerivative · entry 1 Furman Donald Steven · CIK 0001850417 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,826,538 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 18:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 100,000 | $20.11 | $2,010,750.00 |
DisclosureSEC source: 0000950142-21-003813 · es210205303_4-furman.xml · nonDerivative · entry 1 Furman Donald Steven · CIK 0001850417 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,829,544 F1 · kind: Represents 100,000 shares of Common Stock sold pursuant to a registered offering which closed on November 23, 2021, at a price of $20.1075 (net of underwriting discount). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.